India faces antifungal drug shortage as Black Fungus cases add to COVID-19 troubles Kumar Jeetendra | May 21, 2021 India said on May 21 that it is working to alleviate a shortage of a medicine used to treat a rare fungal disease hitting COVID-19 patients as the healthcare system is reeling under a massive wave of coronavirus infections. Cases of Mucormycosis, or Black Fungus, a potentially serious complication that causes blurred or double vision, …
Bajaj Healthcare launches drug to treat black fungus infection in COVID-19 patients Kumar Jeetendra | May 28, 2021 Bajaj Healthcare on Friday launched Posaconazole API, used in treating Mucormycosis (black fungus) infection in COVID-19 patients. The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing. Bajaj Healthcare …
HiMedia introduces Mucormycosis detection kit, MUCOdiagno to isolate fungi from Mucormycosis patients Kumar Jeetendra | June 11, 2021 HiMedia Laboratories, a bioscience company with expertise in media manufacturing and diagnostics, has developed the Mucormycosis detection kit for mucormycosis patients. The kit has been introduced under the brand name MUCO-diagnoTM [K144], which is a complete kit for clinicians to collect the sample and isolate the fungi responsible for Mucormycosis from patient’s sample. Commenting on …
Cadila Pharma launches Posaconazole for treatment of fungal diseases Kumar Jeetendra | June 21, 2021 21 June 2021, Ahmedabad: Pharma major Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of invasive fungal diseases. The drug has also been recommended as a second-line treatment for Mucormycosis or black fungus as it is commonly known. Posaconazole is approved for …
